샘플 요청 목록

 카트 문의
시장보고서
상품코드
1874397

세계의 의약품 추적 관리 솔루션 : 시장 점유율과 순위, 전체 판매량 및 수요 예측(2025-2031년)

Pharma Track and Trace Solutions - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
발행일: | 리서치사: QYResearch | 페이지 정보: 영문 | 배송안내 : 2-3일 (영업일 기준)

    
    
    




■ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송일정은 문의해 주시기 바랍니다.

세계의 의약품 추적 관리 솔루션 시장 규모는 2024년에 22억 2,300만 달러로 추정되며, 2025-2031년의 예측 기간에 CAGR 15.5%로 성장하여 2031년까지 60억 1,300만 달러로 확대될 것으로 예측됩니다.

추적관리 솔루션은 공급망 효율화를 위한 단순한 경제적 대책이 아닙니다. 전문가들에 따르면 전 세계에서 판매되는 의약품의 5%가 위조품으로 추정되며, 일부 국가에서는 그 비율이 무려 50%에 달하는 경우도 있다고 합니다. 매년 수십억 개의 제품이 '공급망 내에서 손실'되고 있습니다. 위조 의약품 및 제품의 부정 유통은 인명을 위험에 빠뜨리고, 수익을 훼손하며, 기업의 평판을 위협합니다. 제약업계는 공급망의 안전성을 확보하고, 제품의 전자 혈통서(ePedigree), 즉 라이프 히스토리를 인증할 수 있는 능력을 확보해야 합니다. 추적 관리 솔루션은 이 전략의 필수적인 요소입니다. 추적 관리 솔루션은 제약 산업 제품의 원산지를 식별하고 진위 여부를 확인합니다. 또한, 추적 관리 솔루션은 제품 유용 방지에도 기여합니다. 유용은 정식 제품이 시장 간 부정하게 이동하는 행위로, 라이선싱 의무, 유통 계약, 수익에 영향을 미칩니다.

의약품 추적 관리 솔루션 시장은 전 세계적으로 의약품 공급망 안전과 환자 안전에 대한 관심이 높아짐에 따라 주도되고 있습니다. 위조 의약품이 시중에 유통되는 사례가 증가함에 따라 각국 규제 당국은 미국 의약품 공급망 안전법(DSCSA), 유럽 연합 위조 의약품 지침(FMD), 기타 지역의 유사 규제 등 엄격한 일련번호 및 추적성 의무를 시행하고 있습니다. 이러한 규제 요건으로 인해 제약사들은 법적 기준을 준수하고 처벌을 피하기 위해 고도의 추적 및 이력추적 기술을 도입해야 합니다. 또한, 여러 지역에 분산된 여러 이해관계자가 관여하는 세계 의약품 공급망의 복잡성이 증가함에 따라, 엔드투엔드 가시성과 투명성을 제공하는 강력한 솔루션이 필수적입니다. 블록체인, RFID, 사물인터넷(IoT)과 같은 혁신적인 기술의 채택은 실시간 모니터링 능력 강화와 데이터 무결성 확보를 통해 시장 성장을 더욱 가속화할 것입니다. 또한, 의약품의 진품성과 안전성에 대한 소비자 및 의료 서비스 제공업체의 인식이 높아짐에 따라 신뢰할 수 있는 추적 시스템에 대한 수요가 증가하고 있습니다. 제약사 및 기술 제공업체들이 비용 효율적이고 확장 가능하며 상호 운용 가능한 추적 및 추적성 솔루션 개발에 투자하는 것도 시장 확대에 큰 기여를 하고 있습니다.

유망한 성장 전망에도 불구하고, 의약품 추적 관리 솔루션 시장은 발전을 저해할 수 있는 몇 가지 문제에 직면해 있습니다. 주요 장벽 중 하나는 첨단 추적 기술의 도입 비용이 높다는 점입니다. 특히 신흥 시장에서 사업을 전개하는 중소형 제약사의 경우, 인프라 업그레이드, 직원 교육, 기존 기업 시스템과의 통합에 많은 자본과 시간이 필요하기 때문에 도입이 지연될 수 있습니다. 또한, 표준화된 세계 규정의 부재와 국가별 컴플라이언스 요건의 차이로 인해 복잡성과 파편화가 발생하여 제조업체가 전 세계적으로 통일된 솔루션을 도입하는 데 어려움을 겪고 있습니다. 서로 다른 추적 시스템 간의 상호운용성 문제와 데이터 프라이버시에 대한 우려도 심각한 장벽이 되고 있습니다. 또한, 위조범과 공급망 범죄자들의 끊임없이 진화하는 수법에 대응하기 위해 추적 솔루션의 지속적인 혁신과 업데이트가 필요하며, 이는 운영상의 어려움을 가중시키고 있습니다. 기존 공급망 네트워크 내 변화에 대한 저항과 다양한 이해관계자간의 협력의 필요성도 도입 노력을 더욱 복잡하게 만들고 있습니다. 이러한 문제를 해결하는 것은 의약품 공급망을 보호하고 환자의 안전을 보장하기 위해 의약품 추적 시스템의 잠재력을 최대한 발휘하는 데 매우 중요합니다.

이 보고서는 의약품 추적 관리 솔루션 세계 시장에 대해 총 매출액, 주요 기업의 시장 점유율 및 순위를 중심으로 지역별, 국가별, 유형별, 용도별 분석을 종합적으로 제시하는 것을 목적으로 합니다.

의약품 추적 관리 솔루션 시장 규모, 추정 및 예측은 2024년을 기준 연도로 하여 2020년에서 2031년까지의 과거 데이터와 예측 데이터를 포함하는 매출액으로 제시되었습니다. 정량적, 정성적 분석을 통해 독자들이 의약품 추적/추적 솔루션에 대한 사업/성장 전략 수립, 시장 경쟁 평가, 현재 시장에서의 포지셔닝 분석, 정보에 입각한 사업적 판단을 내릴 수 있도록 돕습니다.

시장 세분화

기업별

  • Optel Vision
  • Siemens
  • IBM
  • Axway
  • Mettler-Toledo
  • Systech
  • SAP
  • Seidenader Maschinenbau
  • Antares Vision
  • Sea Vision
  • TraceLink
  • Adents International
  • Xyntek
  • Holoflex
  • ACG Worldwide

유형별 부문

  • 바코드
  • RFID

용도별 부문

  • 바이오 의약품
  • 화학 제약
  • 특수 의약품

지역별

  • 북미
    • 미국
    • 캐나다
  • 아시아태평양
    • 중국
    • 일본
    • 한국
    • 동남아시아
    • 인도
    • 호주
    • 기타 아시아태평양
  • 유럽
    • 독일
    • 프랑스
    • 영국
    • 이탈리아
    • 네덜란드
    • 북유럽 국가
    • 기타 유럽
  • 라틴아메리카
    • 멕시코
    • 브라질
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 튀르키예
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 기타 중동 및 아프리카
LSH 25.12.08

자주 묻는 질문

  • 의약품 추적 관리 솔루션 시장 규모는 어떻게 예측되나요?
  • 의약품 추적 관리 솔루션의 주요 기능은 무엇인가요?
  • 의약품 추적 솔루션 시장의 성장 요인은 무엇인가요?
  • 의약품 추적 솔루션 시장이 직면한 주요 문제는 무엇인가요?
  • 의약품 추적 솔루션 시장의 주요 기업은 어디인가요?

The global market for Pharma Track and Trace Solutions was estimated to be worth US$ 2223 million in 2024 and is forecast to a readjusted size of US$ 6013 million by 2031 with a CAGR of 15.5% during the forecast period 2025-2031.

Track and trace solutions are not just economic measures for supply-chain efficiency. Experts estimate that 5% of all drugs sold worldwide are counterfeits - in some countries, figures even reach a shocking 50 %. Billions of products are "lost in the supply chain" every year. Counterfeit drugs and product diversion risk lives, undermine revenues, and threaten company reputations. The pharmaceutical industry needs to ensure supply-chain security and gain the ability to authenticate the ePedigree, or life history, of a product. Track and trace solutions are an essential part of this strategy. Track and trace solutions identify the origins of a pharmaceutical industry product and verify its authenticity. Moreover, track and trace solutions also help combat product diversion, whereby legitimate products are diverted from one market to another, with implications for licensing obligations and distribution agreements as well as for revenues.

The Pharma Track and Trace Solutions market is primarily driven by the growing global emphasis on pharmaceutical supply chain security and patient safety. Increasing incidences of counterfeit drugs flooding the market have pushed regulatory authorities worldwide to implement stringent serialization and traceability mandates, such as the U.S. Drug Supply Chain Security Act (DSCSA), the European Union Falsified Medicines Directive (FMD), and similar regulations in other regions. These regulatory requirements compel pharmaceutical companies to adopt advanced track and trace technologies to comply with legal standards and avoid penalties. Additionally, the rising complexity of global pharmaceutical supply chains, involving multiple stakeholders across geographies, necessitates robust solutions that provide end-to-end visibility and transparency. The adoption of innovative technologies like blockchain, RFID, and Internet of Things (IoT) further accelerates market growth by enhancing real-time monitoring capabilities and ensuring data integrity. Moreover, the increasing awareness among consumers and healthcare providers about drug authenticity and safety is creating demand for reliable tracking systems. Investments by pharmaceutical manufacturers and technology providers in developing cost-effective, scalable, and interoperable track and trace solutions also contribute significantly to market expansion.

Despite the promising growth prospects, the Pharma Track and Trace Solutions market faces several challenges that could impede its progress. One of the main hurdles is the high implementation cost associated with advanced track and trace technologies, especially for small and mid-sized pharmaceutical companies operating in emerging markets. The need for infrastructure upgrades, staff training, and integration with existing enterprise systems requires substantial capital and time investments, which may delay adoption. Furthermore, the lack of standardized global regulations and varying compliance requirements across countries create complexity and fragmentation, making it difficult for manufacturers to implement uniform solutions worldwide. Interoperability issues between different track and trace systems and data privacy concerns also pose significant barriers. Additionally, the constantly evolving tactics of counterfeiters and supply chain criminals require continuous innovation and updates to tracking solutions, increasing operational challenges. Resistance to change within traditional supply chain networks and the requirement for collaboration among diverse stakeholders further complicate deployment efforts. Addressing these challenges is critical for realizing the full potential of pharma track and trace systems in safeguarding the pharmaceutical supply chain and ensuring patient safety.

This report aims to provide a comprehensive presentation of the global market for Pharma Track and Trace Solutions, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pharma Track and Trace Solutions by region & country, by Type, and by Application.

The Pharma Track and Trace Solutions market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharma Track and Trace Solutions.

Market Segmentation

By Company

  • Optel Vision
  • Siemens
  • IBM
  • Axway
  • Mettler-Toledo
  • Systech
  • SAP
  • Seidenader Maschinenbau
  • Antares Vision
  • Sea Vision
  • TraceLink
  • Adents International
  • Xyntek
  • Holoflex
  • ACG Worldwide

Segment by Type

  • Barcodes
  • RFID

Segment by Application

  • Bio Pharma
  • Chemical Pharma
  • Specially Pharma

By Region

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Netherlands
    • Nordic Countries
    • Rest of Europe
  • Latin America
    • Mexico
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
    • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Pharma Track and Trace Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Pharma Track and Trace Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Pharma Track and Trace Solutions in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Pharma Track and Trace Solutions Product Introduction
  • 1.2 Global Pharma Track and Trace Solutions Market Size Forecast (2020-2031)
  • 1.3 Pharma Track and Trace Solutions Market Trends & Drivers
    • 1.3.1 Pharma Track and Trace Solutions Industry Trends
    • 1.3.2 Pharma Track and Trace Solutions Market Drivers & Opportunity
    • 1.3.3 Pharma Track and Trace Solutions Market Challenges
    • 1.3.4 Pharma Track and Trace Solutions Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Pharma Track and Trace Solutions Players Revenue Ranking (2024)
  • 2.2 Global Pharma Track and Trace Solutions Revenue by Company (2020-2025)
  • 2.3 Key Companies Pharma Track and Trace Solutions Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Pharma Track and Trace Solutions Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Pharma Track and Trace Solutions
  • 2.6 Pharma Track and Trace Solutions Market Competitive Analysis
    • 2.6.1 Pharma Track and Trace Solutions Market Concentration Rate (2020-2025)
    • 2.6.2 Global 5 and 10 Largest Companies by Pharma Track and Trace Solutions Revenue in 2024
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharma Track and Trace Solutions as of 2024)
  • 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Barcodes
    • 3.1.2 RFID
  • 3.2 Global Pharma Track and Trace Solutions Sales Value by Type
    • 3.2.1 Global Pharma Track and Trace Solutions Sales Value by Type (2020 VS 2024 VS 2031)
    • 3.2.2 Global Pharma Track and Trace Solutions Sales Value, by Type (2020-2031)
    • 3.2.3 Global Pharma Track and Trace Solutions Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Bio Pharma
    • 4.1.2 Chemical Pharma
    • 4.1.3 Specially Pharma
  • 4.2 Global Pharma Track and Trace Solutions Sales Value by Application
    • 4.2.1 Global Pharma Track and Trace Solutions Sales Value by Application (2020 VS 2024 VS 2031)
    • 4.2.2 Global Pharma Track and Trace Solutions Sales Value, by Application (2020-2031)
    • 4.2.3 Global Pharma Track and Trace Solutions Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

  • 5.1 Global Pharma Track and Trace Solutions Sales Value by Region
    • 5.1.1 Global Pharma Track and Trace Solutions Sales Value by Region: 2020 VS 2024 VS 2031
    • 5.1.2 Global Pharma Track and Trace Solutions Sales Value by Region (2020-2025)
    • 5.1.3 Global Pharma Track and Trace Solutions Sales Value by Region (2026-2031)
    • 5.1.4 Global Pharma Track and Trace Solutions Sales Value by Region (%), (2020-2031)
  • 5.2 North America
    • 5.2.1 North America Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.2.2 North America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.3 Europe
    • 5.3.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.3.2 Europe Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.4.2 Asia Pacific Pharma Track and Trace Solutions Sales Value by Region (%), 2024 VS 2031
  • 5.5 South America
    • 5.5.1 South America Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.5.2 South America Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031
  • 5.6 Middle East & Africa
    • 5.6.1 Middle East & Africa Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 5.6.2 Middle East & Africa Pharma Track and Trace Solutions Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Pharma Track and Trace Solutions Sales Value Growth Trends, 2020 VS 2024 VS 2031
  • 6.2 Key Countries/Regions Pharma Track and Trace Solutions Sales Value, 2020-2031
  • 6.3 United States
    • 6.3.1 United States Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.3.2 United States Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.3.3 United States Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.4 Europe
    • 6.4.1 Europe Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.4.2 Europe Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.4.3 Europe Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.5 China
    • 6.5.1 China Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.5.2 China Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.5.3 China Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.6 Japan
    • 6.6.1 Japan Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.6.2 Japan Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.6.3 Japan Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.7 South Korea
    • 6.7.1 South Korea Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.7.2 South Korea Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.7.3 South Korea Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.8 Southeast Asia
    • 6.8.1 Southeast Asia Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.8.2 Southeast Asia Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.8.3 Southeast Asia Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031
  • 6.9 India
    • 6.9.1 India Pharma Track and Trace Solutions Sales Value, 2020-2031
    • 6.9.2 India Pharma Track and Trace Solutions Sales Value by Type (%), 2024 VS 2031
    • 6.9.3 India Pharma Track and Trace Solutions Sales Value by Application, 2024 VS 2031

7 Company Profiles

  • 7.1 Optel Vision
    • 7.1.1 Optel Vision Profile
    • 7.1.2 Optel Vision Main Business
    • 7.1.3 Optel Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.1.4 Optel Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.1.5 Optel Vision Recent Developments
  • 7.2 Siemens
    • 7.2.1 Siemens Profile
    • 7.2.2 Siemens Main Business
    • 7.2.3 Siemens Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.2.4 Siemens Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.2.5 Siemens Recent Developments
  • 7.3 IBM
    • 7.3.1 IBM Profile
    • 7.3.2 IBM Main Business
    • 7.3.3 IBM Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.3.4 IBM Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.3.5 IBM Recent Developments
  • 7.4 Axway
    • 7.4.1 Axway Profile
    • 7.4.2 Axway Main Business
    • 7.4.3 Axway Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.4.4 Axway Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.4.5 Axway Recent Developments
  • 7.5 Mettler-Toledo
    • 7.5.1 Mettler-Toledo Profile
    • 7.5.2 Mettler-Toledo Main Business
    • 7.5.3 Mettler-Toledo Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.5.4 Mettler-Toledo Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.5.5 Mettler-Toledo Recent Developments
  • 7.6 Systech
    • 7.6.1 Systech Profile
    • 7.6.2 Systech Main Business
    • 7.6.3 Systech Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.6.4 Systech Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.6.5 Systech Recent Developments
  • 7.7 SAP
    • 7.7.1 SAP Profile
    • 7.7.2 SAP Main Business
    • 7.7.3 SAP Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.7.4 SAP Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.7.5 SAP Recent Developments
  • 7.8 Seidenader Maschinenbau
    • 7.8.1 Seidenader Maschinenbau Profile
    • 7.8.2 Seidenader Maschinenbau Main Business
    • 7.8.3 Seidenader Maschinenbau Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.8.4 Seidenader Maschinenbau Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.8.5 Seidenader Maschinenbau Recent Developments
  • 7.9 Antares Vision
    • 7.9.1 Antares Vision Profile
    • 7.9.2 Antares Vision Main Business
    • 7.9.3 Antares Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.9.4 Antares Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.9.5 Antares Vision Recent Developments
  • 7.10 Sea Vision
    • 7.10.1 Sea Vision Profile
    • 7.10.2 Sea Vision Main Business
    • 7.10.3 Sea Vision Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.10.4 Sea Vision Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.10.5 Sea Vision Recent Developments
  • 7.11 TraceLink
    • 7.11.1 TraceLink Profile
    • 7.11.2 TraceLink Main Business
    • 7.11.3 TraceLink Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.11.4 TraceLink Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.11.5 TraceLink Recent Developments
  • 7.12 Adents International
    • 7.12.1 Adents International Profile
    • 7.12.2 Adents International Main Business
    • 7.12.3 Adents International Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.12.4 Adents International Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.12.5 Adents International Recent Developments
  • 7.13 Xyntek
    • 7.13.1 Xyntek Profile
    • 7.13.2 Xyntek Main Business
    • 7.13.3 Xyntek Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.13.4 Xyntek Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.13.5 Xyntek Recent Developments
  • 7.14 Holoflex
    • 7.14.1 Holoflex Profile
    • 7.14.2 Holoflex Main Business
    • 7.14.3 Holoflex Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.14.4 Holoflex Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.14.5 Holoflex Recent Developments
  • 7.15 ACG Worldwide
    • 7.15.1 ACG Worldwide Profile
    • 7.15.2 ACG Worldwide Main Business
    • 7.15.3 ACG Worldwide Pharma Track and Trace Solutions Products, Services and Solutions
    • 7.15.4 ACG Worldwide Pharma Track and Trace Solutions Revenue (US$ Million) & (2020-2025)
    • 7.15.5 ACG Worldwide Recent Developments

8 Industry Chain Analysis

  • 8.1 Pharma Track and Trace Solutions Industrial Chain
  • 8.2 Pharma Track and Trace Solutions Upstream Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Raw Materials Key Suppliers
    • 8.2.3 Manufacturing Cost Structure
  • 8.3 Midstream Analysis
  • 8.4 Downstream Analysis (Customers Analysis)
  • 8.5 Sales Model and Sales Channels
    • 8.5.1 Pharma Track and Trace Solutions Sales Model
    • 8.5.2 Sales Channel
    • 8.5.3 Pharma Track and Trace Solutions Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
      • 10.1.1.1 Research Programs/Design
      • 10.1.1.2 Market Size Estimation
      • 10.1.1.3 Market Breakdown and Data Triangulation
    • 10.1.2 Data Source
      • 10.1.2.1 Secondary Sources
      • 10.1.2.2 Primary Sources
  • 10.2 Author Details
  • 10.3 Disclaimer
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제